XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 31 filers reported holding XENON PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,586,000 | -6.0% | 85,000 | -52.8% | 0.94% | +85.2% |
| Q3 2021 | $2,750,000 | +1378.5% | 180,000 | +1636.6% | 0.51% | +1651.7% |
| Q1 2021 | $186,000 | -82.4% | 10,365 | -87.0% | 0.03% | -87.1% |
| Q3 2018 | $1,056,000 | +420.2% | 80,000 | +220.0% | 0.22% | +215.5% |
| Q3 2016 | $203,000 | – | 25,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |